Rare genetic errors in patient genes and new mutations have been identified by scientists of the Cyprus Institute of Neurology & Genetics (CING) as part of the innovative research program of the Next-generation DNA sequencing technology carried out over the last two years with the financial support of RCB Bank. Typical is the case of a Cypriot family which, thirty years later, has been diagnosed with a rare mutation in the SPG 11 gene, and now relatives can take preventive measures whilst waiting for treatment methods.
CING Identifies Rare Genetic Errors in Patient Genes
